About this pathway
This page is a starting point for learning about peptides discussed in research and public conversation, how they're regulated in Australia, and how the consultation and compounding process works. Each linked article covers one topic in more depth — for general educational purposes only.
Consultation does not guarantee prescription, treatment recommendation, or suitability. Not all individuals will be suitable candidates for prescription-only therapies.
How it flows
One coordinated path
Step 01Initial enquiry
General program information and administrative intake — no clinical assessment at this stage.
Step 02Practitioner consultation
Booked with an independent registered practitioner via a TGA-compliant telehealth platform.
Step 03Clinical assessment
Individual review of health history and current circumstances by the independent practitioner.
Step 04Options considered
Where appropriate, the practitioner discusses available pathways and next steps following review.
- Step 05
Pharmacy fulfilment
Where prescribed, dispensed independently by a licensed Australian pharmacy under its own regulatory obligations.
- Step 06
Ongoing coordination
One inbox for scheduling, follow-up and admin support across the pathway.
Any prescription-only therapies are assessed and prescribed solely by independent, registered healthcare practitioners following individual clinical review where considered appropriate. Not all individuals will be suitable candidates, and practitioner consultations do not guarantee prescription, treatment recommendation, or ongoing eligibility.
How the Australian framework works
Before reading about individual substances, these pages explain the regulatory and process context that applies across all of them:
- Are Peptides Legal in Australia? — why legality depends on the specific substance, not a blanket answer
- Understanding Schedule 4 (Prescription-Only) Medicines — what prescription-only status means and why it varies by substance
- Peptide Quality in Australia: Purity Testing, Heavy Metal Screening, and What to Look For — what compounding quality standards actually cover, and what they don't
- Compounded Peptides vs Online Sources: What to Know — the difference between a licensed compounding pathway and unregulated online sellers
- How to Evaluate a Telehealth Peptide Consultation Service in Australia — what a properly structured service looks like
- What Typically Influences the Cost of a Peptide Consultation in Australia — context on independent practitioner consultation fees
Speak with us directly — start to finish.
Educational reference articles
Research interest often clusters around a few related groups of peptides. These groupings reflect how they're commonly discussed in research and public conversation, not a recommendation to consider them together. Each article is general educational reference material only — not an advertisement, endorsement or recommendation.
Educational reference material
Please confirm before continuing
The pages beyond this point discuss individual substances that are, in most cases, prescription-only (Schedule 4) in Australia and not listed on the ARTG. This material is provided for general educational reference only. It is not an advertisement, endorsement or recommendation for the use, purchase or supply of any therapeutic good, and it is not medical advice. Suitability for any pathway is determined solely by an independent registered practitioner following individual consultation.
Coverage
Concierge coordination Australia-wide
Our enquiry intake and coordination service operates Australia-wide — across the capital cities and regional areas listed here.
A note on this content
Most substances referenced above are not listed on the Australian Register of Therapeutic Goods (ARTG) as approved medicines, meaning they have not been evaluated by the Therapeutic Goods Administration (TGA) for safety, quality, or effectiveness in Australia. A small number — noted individually — do have existing approved uses or overseas regulatory history for specific indications; this does not extend to general or off-label use. Where a legitimate pathway exists for a non-approved substance, it involves an individual prescription from a registered healthcare practitioner and preparation through a licensed Australian compounding pharmacy — not retail or direct purchase.
Disclaimer
This content is for general educational purposes only and does not constitute medical advice. It is not a representation that any substance is safe, effective, or approved for any purpose, and it is not intended to promote the use, purchase, or supply of any therapeutic good. Substances that have not been evaluated by the TGA carry unknown risks, including possible side effects, interactions with other medicines and unknown long-term safety. Most enquiries do not result in a prescription.
GL Vitality Drips operates as a consultation coordination and administrative support service only and does not provide, supply, or grant access to any therapeutic good. GL Vitality Drips does not diagnose, treat, or prescribe. All clinical decisions are made independently by appropriately qualified, registered healthcare practitioners following individual consultation and assessment.
Not every individual will be considered a suitable candidate, and no outcome is guaranteed. Where a prescription is issued, preparation occurs through a licensed Australian compounding pharmacy in accordance with applicable Australian laws and professional standards. Not all individuals will be suitable candidates for prescription-only therapies. Consultation does not guarantee prescription, treatment recommendation, or ongoing eligibility.
Any consultation, assessment or pharmacy dispensing is arranged solely by independent, registered healthcare practitioners and licensed Australian pharmacies, subject to their own eligibility criteria.
Journal
Subscribe to our Journal
Quiet notes on preventative wellness, integrative care and concierge coordination.